Ranitidin-Isis en es it fr

Ranitidin-Isis Brand names, Ranitidin-Isis Analogs

Ranitidin-Isis Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidin-Isis Chemical_Formula


Ranitidin-Isis RX_link


Ranitidin-Isis fda sheet

Ranitidin-Isis FDA

Ranitidin-Isis msds (material safety sheet)

Ranitidin-Isis MSDS

Ranitidin-Isis Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin-Isis Molecular Weight

314.405 g/mol

Ranitidin-Isis Melting Point

69-70 oC

Ranitidin-Isis H2O Solubility

24.7 mg/mL

Ranitidin-Isis State


Ranitidin-Isis LogP


Ranitidin-Isis Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin-Isis Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin-Isis Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin-Isis Absorption

Approximately 50% bioavailability orally.

Ranitidin-Isis side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin-Isis Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin-Isis Organisms Affected

Humans and other mammals